Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial glycoprotein mucins are a family of high molecular weight, heavily glycosylated proteins found on the apical surface of epithelial cells. They provide barrier protection, lubrication, and immune modulation. Aberrant expression and glycosylation are frequently observed in cancer, making them potential therapeutic targets and diagnostic markers.
Variable depending on mucin type; can involve blocking adhesion, modulating immune response, or disrupting barrier function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial Glycoprotein Mucin (Mucin).